VRDN
Viridian Therapeutics Inc.
Company Overview
| Mkt Cap | $1.59B | Price | $23.11 |
| Volume | 763.75K | Change | -2.20% |
| P/E Ratio | -5.9 | Open | $23.50 |
| Revenue | $302.0K | Prev Close | $23.63 |
| Net Income | $-269.9M | 52W Range | $9.90 - $27.20 |
| Div Yield | N/A | Target | $39.87 |
| Overall | 59 | Value | 60 |
| Quality | 44 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyViridian Therapeutics Inc. (VRDN) is a leading Health Care and Social Assistance company in the Medical Laboratories industry, currently trading at $23.63 with a market capitalization of $1.59 billion. The stock is positioned in the upper portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows VRDN with a volume of 1.31 million shares. The stock opened up 0.34% from yesterday's close of $23.66. Current analyst estimates project earnings of $-3.77 per share for this year, with next year targeting $-3.96.
VRDN demonstrates strong technical indicators based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for VRDN include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 68.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:05 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $23.11 | -2.2% | 763.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW